Anixa Biosciences, Inc. (ANIX) Stock Price, News, Quote & History ...
Find the latest Anixa Biosciences, Inc. (ANIX) stock quote, history, news and other vital information to help you with your stock trading and investing.
AniX — Watch Free Anime Online in HD & 4K in 2025
AniX offers the ultimate free anime streaming experience — HD & 4K videos, quick updates, and sub/dub choices. Stream anytime, no sign-up, minimal ads, and works seamlessly on every …
ANIX: Anixa Biosciences Inc Latest Stock Price, Analysis, News …
Get real-time Anixa Biosciences Inc (ANIX) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.
Anixa Biosciences (ANIX) Stock Price, News & Analysis
5 days ago · Anixa Biosciences is a clinical-stage immuno-oncology and infectious disease company developing novel cell-based immunotherapies and vaccine platforms.
Anixa Biosciences (ANIX) Stock Price & Overview
5 days ago · A detailed overview of Anixa Biosciences, Inc. (ANIX) stock, including real-time price, chart, key statistics, news, and more.
Investors :: Anixa Biosciences, Inc. (ANIX)
Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known …
ANIX Stock Price Quote | Morningstar
5 days ago · See the latest Anixa Biosciences Inc stock price (ANIX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Anixa Biosciences, Inc. (ANIX) Jumps 6.9% in Pre-market: What’s …
Dec 8, 2025 · Anixa Biosciences, Inc. (ANIX) has registered a notable increase, trading at $5.12, up 6.9% from its last close of $4.79 in pre-market activity. This move comes amid significant …
Anixa Biosciences - ANIX - Stock Price Today - Zacks
5 days ago · Get the latest ANIXA BIOSCIENCES INC ANIX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Anixa Biosciences Earnings 2025 Annual | ANIX News & Analysis
2 days ago · Anixa Biosciences reported that 74% of subjects in its Phase 1 breast cancer vaccine trial achieved immune responses while maintaining a two-year cash runway through non …